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patients at nutritional risk: Secondary analys u m m a r y
Background: Among medical inpatients at risk of malnutrition, the use of individualized nutritional
support during the hospital stay was found to reduce complications and improve mortality at short-term.
We evaluated clinical outcomes at 6-months follow-up.
Methods: We randomly assigned 2028 patients to receive protocol-guided individualized nutritional
support to reach protein and energy goals (intervention group) or hospital food as usual (control group)
during the hospital stay. The intervention was discontinued at hospital discharge and further nutritional
support was based on the discretion of the treating team. We had complete follow-up information of
1995 patients (98%), which were included in the final analysis. The primary endpoint was all-cause
mortality at 6-months. Prespecified secondary end points included non-elective hospital readmissions,
functional outcome and quality of life.
Results: At 6-month, 231 of 994 (23.2%) intervention group patients had died compared to 246 of 999
(24.6%) control group patients, resulting in a hazard ratio for death of 0.90 (95%CI 0.76 to 1.08, p ¼ 0.277).
Compared to control patients, intervention group patients had similar rates of hospital readmission
(27.3% vs. 27.6%, HR 1.00 (95%CI 0.84 to 1.18), p ¼ 0.974), falls (11.2% vs. 10.9%, HR 0.96 (95%CI 0.72 to 1.27),
p ¼ 0.773) and similar quality of life and activities of daily living scores.
Interpretation: While individualized nutritional support during the hospital stay significantly reduced
short-term mortality, there was no legacy effect on longer term outcomes. Future trials should investi-
gate whether continuation of nutritional support after hospital discharge reduces the high malnutrition-
associated mortality rates in this vulnerable patient population.nt of Medicine Kantonsspital Aarau Tellstrasse, CH-5001, Aarau, Switzerland. Fax: þ41 62 838 4100.
).
r Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
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Malnutrition is a serious public health problem affecting
30e50% of medical inpatients [1e4]. Acute and chronic illnesses
have strong effects on protein and energy homeostasis, protein
catabolism, hormonal function and appetite leading to weight loss
and sarcopenia with progressive deterioration of nutritional status
[5]. Poor nutritional status, in turn, is associated with higher mor-
tality and morbidity, functional decline, prolonged hospital stay,
and increased health care costs [2,6]. To prevent these
malnutrition-related adverse medical outcomes, current clinical
nutrition guidelines from the European Society for Clinical Nutri-
tion and Metabolism (ESPEN) [4] and the American Society for
Parenteral and Enteral Nutrition (ASPEN) [7] recommend an active
approach with early start of nutritional support in hospitalized
patients at nutritional risk. These recommendations are based on
physiological rationales and also several randomized trials and
meta-analyses of such trials showing that nutritional support
provided during hospitalization has a beneficial effect on clinical
outcomes [8e12]. Among these trials, the Effect of early nutritional
support on Frailty, Functional Outcomes and Recovery of malnour-
ished medical inpatients Trial (EFFORT) recently reported positive
effects of individualized nutritional support during the hospital
stay in medical inpatients at risk for malnutrition [13]. Intervention
group patients included in EFFORT received protocolized individual
nutritional support to reach protein and energy goals, which was,
however, terminated after hospital discharge. Compared to control
group patients, patients receiving individual nutritional support
had a significant reduction in risks for complications and mortality
at short-term, i.e., within 30 days, with also improvements in
quality of life and functional outcomes.
Still, it remains unclear whether an intervention that focuses on
the inpatient time period only will affect clinical outcomes over a
prolonged period, or whether additional nutritional interventions
in the outpatient setting would be necessary to improve and sus-
tain malnutrition-related adverse outcomes and mortality. Herein,
we evaluated the predefined clinical outcomes at 6-months follow-
up in participants included in the EFFORT trial [13].
2. Materials and methods
2.1. Study design, registration and oversight
EFFORT was a pragmatic, investigator-initiated, open-label, non-
blinded, randomized-controlled trial, that was undertaken in eight
Swiss hospitals. The rationale for the trial, design details, and eligi-
bility criteria have been published previously [14]. Also, the main
analysis including all short-term outcomes within 30 days has been
published [13]. The ethical committee of the Northwestern part of
Switzerland (EKNZ; 2014_001) approved the study protocol for all
participating sites, and the trial was registered at ClinicalTrials.gov in
August 2015 (https://clinicaltrials.gov/ct2/show/NCT02517476). All
patients gave written informed consent for participation in the trial.
2.2. Sites, patient selection and randomization
Participating sites were secondary and tertiary care hospitals in
Switzerland, and all routinely screened patients for risk ofl., Six-month outcomes after
sis of a prospective randomizmalnutrition with the Nutritional Risk Screening 2002 (NRS)
[15,16]. NRS includes assessment of the patient's nutritional status
(based on weight loss, body mass index (BMI) and general condi-
tion or food intake) and disease severity (stress metabolism), and a
higher score is associated with higher risk for adverse outcomes. To
be eligible for the trial, a NRS total score of 3 points or more was
mandatory. Additionally, we only included patients with an ex-
pected length of hospital stay of 5 days. The trial had different
exclusion criteria, including initial admission to an intensive care
unit or surgical unit, inability to ingest oral nutrition, ongoing
nutritional treatment before trial inclusion, terminal conditions
(i.e., end-of-life situation), anorexia nervosa, acute pancreatitis and
liver failure, cystic fibrosis or stem cell transplantation, history of
gastric bypass surgery, and any contraindications for nutritional
support. Also, patients previously included in the trial were not
allowed to be included in the trial again during follow-up.
Patients were randomly assigned in a 1:1 ratio with variable
block size, stratified according to site and the severity of malnu-
trition, with the use of an interactive web-response system, to
receive either individualized nutritional support (intervention
group) or hospital food as usual (control group).
2.3. Study interventions
The nutritional support intervention focused on nutritional
treatment during the initial hospital stay. All intervention group
patients received individual nutritional support within 48 h after
admission to reach protein and energy goals according to a previ-
ously published consensus protocol [17] and in accordance with
recent international guidelines [4]. Individualized energy and
protein goals were defined for each individual patient upon hos-
pital admission by a trained registered dietician. We used the
weight-adjusted HarriseBenedict equation to estimate energy re-
quirements [18]. Daily protein intake goals were set at 1.2e1.5 g/kg
body weight per day [19]. For patients with renal failurewe defined
lower targets (0.8 g per kg of body weight). To reach these goals, an
individual nutritional plan was developed by a trained registered
dietician for each patient. This plan was initially based on oral
nutrition provided by the hospital kitchen (including adaptation of
meals to patient's preferences, additional nutritionally dense
snacks and fortified foods) and oral nutritional supplements
[10,20]. A further increase in nutritional support to enteral tube
feeding or parenteral feeding was recommended if at least 75% of
energy and protein targets could not be reached through oral
feeding within 5 days, which was, however, rarely the case.
Nutritional intake was reassessed every 24e48 h throughout the
hospital stay by a trained registered dietician based on daily food
records for each patient.
All intervention group patients received dietary counseling
addressing malnutrition at hospital discharge. Even though
continuation of nutritional support interventions in the outpa-
tient setting were not generally recommended in the protocol and
remained at the discretion of the treatment team, about 1 patient
in 4 did receive continued nutritional support after hospital
discharge.
Control group patients received hospital food as usual according
to their ability and desire to eat, with no nutritional counseling and
no recommendation for additional nutritional support.individualized nutritional support during the hospital stay in medical
ed trial, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2020.08.019
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The primary endpoint of the present analysis was all-cause
mortality within 6-months follow-up. Secondary endpoints
included non-elective hospital readmissions, falls with and without
fractures, weight change and quality of life and functionality scores.
To assess activities of daily living, we used the Barthel's index with
(scores ranging from 0 to 100 and higher scores indicating better
functional status [21]. Quality of life was assessed with the Euro-
pean Quality of Life 5 Dimensions index (German Version, EQ-5D
index) with values ranging from 0 to 1 and higher scores indi-
cating better quality of life. This also includes a visualeanalogue
scale (EQ-5D VAS) with a score ranging from 0 to 100 and higher
scores indicating better health status.
All outcome data were obtained through systematic telephone
calls at day 180 after trial inclusion, which were conducted blinded
to group assignment. Mortality of patients during follow-up was
verified by inquiring family members or the patient's family
physician.2.5. Statistical analysis
The sample-size calculation and the design for the short-term
(30-day) analysis have been described previously [13,14]. For the
6-months analysis, data were included for all the patients who had
more than 30 days of follow-up. All analyses were performed ac-
cording to the intention-to-treat principle. The 6-months event
rates were the percentages of patients who died within 180 days
after randomization. We fitted a cox regression model adjusted for
main prognostic factors (Barthel's index and NRS scores at baseline)
and study center as predefined in the study protocol. We report
hazard ratios (HRs) and corresponding 95% confidence intervals
(CI's). We used a similar statistical approach for secondaryFig. 1. Flow of
Please cite this article as: Kaegi-Braun N et al., Six-month outcomes after
patients at nutritional risk: Secondary analysis of a prospective randomizendpoints, with use of linear regression models for continuous
outcomes. For graphical display, we also used the KaplaneMeier
method to calculate the probability of the primary outcome and
all-cause mortality within 180 days of randomization. We also
performed a post hoc landmark analysis using a cutoff point of 30
days after randomization, with HRs calculated separately for events
that occurred within 30 days and those that occurred between 30
days and 6 months.
We conducted all analyses with STATA 15.1 (StataCorp. 2015.
Stata Statistical Software: Release 15. College Station, TX, USA: Sta-
taCorp LP).3. Results
3.1. Patients
From April 2014 to February 2018 we screened 5015 patients
and included 2028 into the initial analysis at 30 days post
randomization. During the 6-month follow-up, 35 patients (1.7%)
were lost to follow-up. The final analysis cohort consisted of 994
intervention group patients and 999 control group patients (Fig. 1).
The mean age of patients was 73 years, 52% were male, mean
BMI was 24.8 kg/m2 and 31%, 38% and 31% of patients had a NRS
score of 3, 4 and  5, respectively. The main diagnoses for hospital
admission were infections (30%), cancer illness (19%), cardiovas-
cular disease (10%) and frailty (9%). Overall, patients had a high
burden of comorbidities particularly coronary heart disease (28%),
congestive heart failure (18%), cancer (33%), chronic kidney disease
(32%) and diabetes (21%). Baseline characteristics were similar be-
tween groups in regard to age, gender, nutritional risk main diag-
nosis at hospital admission and comorbidities. Baseline
characteristics stratified according to randomization arm are pre-
sented in Table 1.patients.
individualized nutritional support during the hospital stay in medical
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Table 1
Baseline characteristics of Patients. Percentages may not total 100 because of rounding.
Characteristic Control group (N ¼ 999) Intervention group (N ¼ 994) p-value
Socio-demographics
Age - yr 73.0 (13.9) 72.7 (13.9) 0.70
Male sex - no. (%) 531 (53.2%) 510 (51.3%) 0.41
Nutritional history
aBody Mass Index (BMI) - kg/m2 24.7 (5.2) 24.9 (5.4) 0.39
Body weight - kg 70.9 (16.3) 71.0 (17.1) 0.52
bNutritional risk screening score 2002 - no. (%)
3 points 310 (31.0%) 302 (30.4%) 0.96
4 points 377 (37.7%) 381 (38.3%)
5 points 258 (25.8%) 261 (26.3%)
>5 points 54 (5.4%) 50 (5.0%)
Main diagnosis at hospital presentation - no. (%)
Cardiovascular disease 113 (11.3%) 92 (9.3%) 0.13
Infection 311 (31.1%) 294 (29.6%) 0.45
Metabolic disease 29 (2.9%) 29 (2.9%) 0.98
Gastrointestinal disease 67 (6.7%) 96 (9.7%) 0.016
Renal disease 34 (3.4%) 32 (3.2%) 0.82
Cancer 171 (17.1%) 197 (19.8%) 0.12
Lung disease 75 (7.5%) 50 (5.0%) 0.023
Neurological disease 51 (5.1%) 40 (4.0%) 0.25
Failure to thrive 94 (9.4%) 93 (9.4%) 0.97
Other 25 (2.5%) 28 (2.8%) 0.66
Comorbidities - no. (%)
Coronary heart disease 276 (27.6%) 285 (28.7%) 0.60
Chronic heart failure 179 (17.9%) 174 (17.5%) 0.81
Hypertension 546 (54.7%) 553 (55.6%) 0.66
Cerebrovascular disease 87 (8.7%) 74 (7.4%) 0.30
Peripheral arterial disease 104 (10.4%) 79 (7.9%) 0.057
Chronic renal failure 316 (31.6%) 317 (31.9%) 0.90
Diabetes 210 (21.0%) 212 (21.3%) 0.87
COPD 155 (15.5%) 145 (14.6%) 0.56
Dementia 36 (3.6%) 38 (3.8%) 0.80
Malignant disease 327 (32.7%) 333 (33.5%) 0.72
COPD denotes chronic obstructive pulmonary disease.
Metabolic disease included hypoglycemia, hyperglycemia, ketoacidosis, electrolyte disturbances including hyponatremia and hypernatremia, hypokalemia and hyperkalemia
among others.
a The body-mass index is the weight in kilograms divided by the square of the height in meters.
b Total score on nutritional risk screening ranges from 0 to 7, with a score of 3 identifying patients at nutritional risk and higher scores indicating higher risk.
N. Kaegi-Braun et al. / Clinical Nutrition xxx (xxxx) xxx43.2. Nutritional intake during the trial and upon hospital discharge
During the trial, significantly more intervention group patients
reached energy and protein goals compared to control groupTable 2
Primary and secondary endpoints.
Intervention group (N ¼ 994) Cont
Variable
Primary outcome - no (%)
All-cause mortality 231 (23.2%) 246
Secondary outcomes - no (%)
Non-elective hospital readmission 274 (27.6%) 273
Falls 108 (10.9%) 112
Falls with fracture 18 (1.8%) 14 (1
Quality of life and functional outcomes
Activities of daily living
Barthel score - points 13.6 (±7.9) 13.4
Decline in functional status of 10% 916 (92.2%) 928
Quality of Life
EQ-5D Visual-analogue scale - points 50.9 (±34.9) 50.7
EQ-5D index 0.83 (±0.21) 0.83
Weight change
Weight at 6-months (kg) 70.0 (±16.0) 69.0
Weight change from baseline to 6-months (kg) 0.80 (±6.1) 0.9
All hazard ratios were calculated with cox regression for time to event data and linear reg
score, baseline Barthel index) and study center.
For decline in functional status we used the Barthel index and compared initial scores on
European Quality of Life 5 Dimensions.
To estimate decline in functional status we used the Barthel index (scores range from 0
scores on admission with scores at 6-month; To estimate quality of life we used the Euro
scores indicating better quality of life) including the visualeanalogue scale (EQ-5D VAS)
Please cite this article as: Kaegi-Braun N et al., Six-month outcomes after
patients at nutritional risk: Secondary analysis of a prospective randomizpatients (energy goals were reached in 79% and protein goals in 76%
of intervention group patients vs. 54% and 55% in control group
patients). On hospital discharge, oral nutritional supplements were
prescribed in 241/994 (24.2%) of patients in the intervention grouprol group (N ¼ 999) p-value Regression analysis (HR or coefficient and 95%CI)
(24.6%) 0.47 0.90 (0.76e1.08), p ¼ 0.277
(27.3%) 0.91 1.00 (0.84e1.18), p ¼ 0.974
(11.2%) 0.80 0.96 (0.72e1.27), p ¼ 0.773
.4%) 0.47 1.27 (0.63e2.58), p ¼ 0.506
(±8.1) 0.61 0.27 (0.43 to 0.97), p ¼ 0.447
(92.9%) 0.53 0.41 (5.01 to 5.83), p ¼ 0.882
(±35.5) 0.90 1.16 (3.34 to 1.02), p ¼ 0.296
(±0.21) 0.81 0.00 (0.02 to 0.02), p ¼ 0.802
(±16.0) 0.23 1.11 (0.51 to 2.73), p ¼ 0.180
0 (±6.0) 0.71 0.06 (0.57 to 0.68), p ¼ 0.862
ression for continuous data. Models were adjusted for prognostic factors (initial NRS
admission with scores at 6-month; CI denotes confidence interval. EQ-5D denotes
to 100, with higher scores indicating better functional status) and compared initial
pean Quality of Life 5 Dimensions index (values range from 0.205 to 1, with higher
(scores range from 0 to 100, with higher scores indicating better health status).
individualized nutritional support during the hospital stay in medical
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N. Kaegi-Braun et al. / Clinical Nutrition xxx (xxxx) xxx 5compared to 21/999 (2.1%) of patients in the control group. The
initial weight was similar in both groups and (70.9 and 71 kg) and
decreased similarly over 6-months in both groups by 0.9 and 0.8 kg
with no difference between groups.
3.3. Primary endpoint: mortality at 6-months
Within 6 months, 231 of 994 (23.2%) died in the intervention
group compared to 246 of 999 patients (24.6%) in the control group
(adjusted hazard ratio 0.90 [95%CI 0.76 to 1.08], p¼ 0.277) (Table 2).
Kaplan Meier estimates showed a non-significant difference be-
tween groups in regard to the time to death (Fig. 2A).
A post-hoc landmark analysis revealed a difference between the
two groups in mortality within the first 30 days (adjusted HR 0.66
(95%CI, 0.48 to 0.89), p ¼ 0.007), but mortality was similar in theFig. 2. KaplaneMeier estimates of the cumulative incidence of all-cause mortality (A) and
within 6-months (p log rank 0.45). Panel B shows the Landmark analysis for the time to de
Please cite this article as: Kaegi-Braun N et al., Six-month outcomes after
patients at nutritional risk: Secondary analysis of a prospective randomiztwo groups thereafter with 154 dying in the intervention group and
145 patients the in the control group (HR, 1.06 (95% 0.85 to 1.33),
p ¼ 0.595) (Fig. 2B). Predefined subgroup analyses revealed con-
sistency of the results across all subgroups (Fig. 3).
3.4. Secondary endpoints
Secondary outcomes are shown in Table 2. There was no dif-
ference in the rates of non-elective hospital readmission, falls and
fractures due to falls in the 6-months follow-up. Activities of daily
living measured with the Barthel index were similar at 6-months
with also similar proportion of patients showing a decline of
10% from baseline. Also, there was no difference in quality of life
using the EQ5D questionnaire overall, and for the visual analog
scale.Landmark analysis (B). Panel A shows the KaplaneMeier curves for the time to death
ath after 30 days (p log rank 0.52).
individualized nutritional support during the hospital stay in medical
ed trial, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2020.08.019
Fig. 3. Hazard ratios for all-cause mortality (primary outcome) in prespecified subgroups. There were no significant interactions between group assignment and any of the
subgroups tested. The body-mass index is the weight in kilograms divided by the square of the height in meters. NRS denotes nutritional risk screening 2002.
N. Kaegi-Braun et al. / Clinical Nutrition xxx (xxxx) xxx64. Discussion
EFFORT, as a multicenter randomized trial, compared clinical
effects of individualized nutritional support during the hospital
stay with the provision of usual care (routine hospital food) in
medical inpatients at nutritional risk. We previously reported that
the risk for treatment failure and death from any cause was lower
with individual nutritional support in the 30-day analysis of this
trial [13]. In the present analysis, we found that mortality did not
differ significantly between the two groups at 6-month post
randomization. The same was true for secondary endpoints,
including rehospitalization, falls and activities of daily living as well
as quality of life scores.
Importantly, the EFFORT trial investigated the effects of
providing nutritional support during the acute phase of illness in
hospitalized patients. With an average hospital length of stay of 10
days, the individual nutritional support intervention period was
short and only about one fourth of patients received further
nutritional support in the outpatient setting after hospital
discharge. This may explain while outcomes at short term showed
a significant benefit in our trial, but not over a prolonged follow-
up period of 6 months. Importantly, several trials such as the
NOURISH trial that offered continued nutritional support in the
outpatient setting reported also significant effects of nutritional
support on mortality at longer term [9,22,23]. Thus, there is a
strong rationale to continue individual nutritional support for
patients discharged from the hospital with existing risk for or
manifest malnutrition. However, there is need for additional
research to confirm this hypothesis in a well-conducted and
robust trial.Please cite this article as: Kaegi-Braun N et al., Six-month outcomes after
patients at nutritional risk: Secondary analysis of a prospective randomizThere is increasing evidence showing the beneficial effects of
nutritional interventions on medical outcomes in at-risk patients
[8,24,25]. A recent meta-analysis confirmed that nutritional sup-
port during the hospital stay is associated with a 27% reduction in
the odds of mortality [8]. Additionally, the risk for rehospitalization
and prolonged length of hospital stays were improved in patients
receiving individual nutritional support compared to control pa-
tients. Also, from a cost-benefit perspective, nutritional support has
been shown to be highly cost-efficient because the costs for dietary
counseling and nutritional products are relatively low compared to
potential high savings when complications or hospital read-
missions are reduced [26e28]. Future research should also look at
cost-benefits of continued individual nutritional support in the
outpatient setting by comparing costs of the intervention to po-
tential benefits for the patient and the payer.
Within the EFFORT trial, we included a broad and unselected
population of consecutive multimorbid medical inpatients with
different acute illnesses and chronic co-morbidities. While the
short-term beneficial effects of nutritional support were robust and
similar in subgroups according to patient age, gender, severity of
nutritional risk and underlying disease, none of the subgroups
showed benefit at long term. Interestingly, while the short-term
effects were more pronounced in patients with chronic kidney
disease, a condition known to predispose patients to protein-
energy wasting [29], this group of patients did not show signifi-
cant benefit over 6-month, indeed. Still, the relatively small number
of patients with chronic kidney disease included in that subgroup
and the overall short period of nutritional intervention may explain
the absence of significant results. Future studies should focus on
the vulnerable group of patients with chronic kidney disease inindividualized nutritional support during the hospital stay in medical
ed trial, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2020.08.019
N. Kaegi-Braun et al. / Clinical Nutrition xxx (xxxx) xxx 7regard of nutritional support interventions, and also aim to identify
predictors for treatment response e or non-response to further
increase the efficacy of this intervention [30,31].
Our trial has limitations. First, our intervention focused mainly
on the hospital stay and only a minority of patients received
nutritional support in the outpatient setting after discharge. In fact,
in both groups patients lost weight between baseline and the 6-
month follow-up period (0.90 Kg in the control group
and 0.80 Kg in the intervention group), which may suggest a
further deterioration on nutritional status post hospital discharge.
Weight at follow-up was reported by patients, but not measured
centrally. Also, about 20% of intervention group patients did not
fully reach energy and protein goals despite use of the nutritional
protocol implemented by trained dieticians. Similar to real-life
experience, several patient, treatment, and hospital factors (e.g.,
delay or refusal to start enteral or parenteral nutrition by the pa-
tient, early discharge of patients, diagnostic exams interfering with
nutritional support) may have prevented full adherence to the
protocol. Second, EFFORT was a pragmatic trial, and blinding of
participants and personnel was deemed to be impractical. Still,
outcomes assessed after 30-days and 6-months were blinded.
Third, our control group received hospital food as usual, which may
vary from hospital to hospital and within countries. Forth, our trial
design does not allow to make firm conclusions regarding the un-
derlying reasons for lack of effect at long-term. This may be due to
the lack of continuing the nutritional intervention with individu-
alized use of proteins and calories, lack of use of micronutrients,
lack of dietician involvement, among others. Also, the high burden
of disease including cancer and heart disease put the patient pop-
ulation at high risk for reaching the primary endpoint of our
analysis (mortality) and thus may lead to underestimation of any
positive effects of nutrition in acutely ill patients suffering less
severe or less lethal comorbidity.
Understanding the optimal use of individual nutritional support
to effectively prevent and treat malnutrition is highly complex.
Particularly, the optimal timing of nutritional support in regard to
best time to start nutrition and optimal duration of the intervention
have not well been established. The EFFORT trial showed that a
nutritional intervention to reach protein and energy goals in
medical inpatients at nutritional risk that focuses on the inpatient
setting effectively reduces the risk of adverse outcomes and mor-
tality within 30 days, but there is no apparent legacy effect. There is
now a strong need to study effects of outpatient nutritional support
interventions (possibly combined with other strategies to increase
muscle mass, such as increased physical activity) in the nutrition-
ally vulnerable population of medical patients.
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